Political Integrity Network
HR 586 · 119th Congress · House

Vietnam Veterans Liver Fluke Cancer Study Act

In committee
IntroducedJan 21, 2025
Policy areaArmed Forces and National Security
Cosponsors8
What this bill is intended to do

Vietnam Veterans Liver Fluke Cancer Study Act This bill requires the Department of Veterans Affairs (VA) to conduct an epidemiological study and report on the prevalence of cholangiocarcinoma (bile duct cancer) in veterans who served in the Vietnam theater of operations during the Vietnam era. The study must identify the rate of incidence of cholangiocarcinoma in such veterans and in U.S. residents. The bill also requires the VA to track and report on the prevalence of cholangiocarcinoma using the Veterans Affairs Central Cancer Registry. Additionally, the VA must periodically submit follow-up reports to Congress regarding the epidemiological study and information collected from the cancer registry regarding the prevalence of bile duct cancer.

Latest action

Apr 8, 2025Received in the Senate and Read twice and referred to the Committee on Veterans' Affairs.

How Congress voted · House roll call 89 · Apr 7, 2025
411 Yea0 Nay22 Not voting

Passed

How each party voted
Republicans206–0
Democrats204–0
Independents1–0

Revealed positions from the official roll call.

B72

The Vietnam Veterans Liver Fluke Cancer Study Act mandates a study on the prevalence of cholangiocarcinoma among Vietnam veterans. It requires the Secretary of Veterans Affairs to report findings and recommendations to Congress, ensuring ongoing tracking and updates. The bill focuses on data collection and analysis without direct financial implications.

Category gradesMembers of The Quiet Ledger see the full per-category breakdown of how this bill was graded.